Upstart private equity firm Prime Radiant Partners is investing $50 million in Cellares, as the biotechnology company making high-tech robots to mass-produce cancer treatments raises money ahead of a potential initial public offering in 2027.
Upstart private equity firm Prime Radiant Partners is investing $50 million in Cellares, as the biotechnology company making high-tech robots to mass-produce cancer treatments raises money ahead of a potential initial public offering in 2027.
<iframe src="https://statesidedaily.com/embed/cluster/3c18fa1ac8953e9bcc7956eb4946841f37885dd0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Prime Radiant Invests $50 Million in Cellares Pre-IPO"></iframe>
